Communiqués Hofseth BioCare ASA

Actions

HBC

NO0010598683

Transformation des aliments

Temps réel Oslo Bors 09:33:42 21/09/2026			Varia. 5j.	Varia. 1 janv.
1,380 ^NOK	+3,76%		+6,15%	+4,55%

18/09	Un membre du conseil d'administration de Hofseth BioCare acquiert 2,5 millions d'actions	RE
21/08	Hofseth BioCare ASA publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI

Communiqués

17/09	Hofseth BioCare ASA: PRIMARY INSIDER NOTIFICATION	GL
01/09	HOFSETH BIOCARE ASA: MANAGEMENT CHANGE	GL
24/08	Hofseth BioCare ASA: SECOND QUARTER 2026 FINANCIAL REPORT	AQ
21/08	Hofseth BioCare ASA: SECOND QUARTER 2026 FINANCIAL REPORT	GL
07/08	Notification of Major Holdings	GL
06/08	NOTIFICATION OF MAJOR SHAREHOLDINGS	GL
06/08	HOFSETH BIOCARE ASA: NEW SHARE CAPITAL REGISTERED	GL
31/07	Hofseth Biocare ASA: Notification of major shareholdings	GL
30/07	HOFSETH BIOCARE ASA: EXTRAORDINARY GENERAL MEETING COMPLETED	GL
30/07	HOFSETH BIOCARE ASA: EXTRAORDINARY GENERAL MEETING COMPLETED	AQ
27/07	Hofseth BioCare ASA: NEW PEER-REVIEWED CLINICAL STUDY ON PROGO® PUBLISHED IN BIOMEDICINES DEMONSTRATES GLP-1 BENEFITS AND AN INCREASE LEAN MUSCLE MASS	GL
09/07	HOFSETH BIOCARE ASA: NOTICE OF EXTRAORDINARY GENERAL MEETING	GL
07/07	HOFSETH BIOCARE ASA: MAJOR SHAREHOLDER NOTIFICATION	GL
03/07	HOFSETH BIOCARE ASA: NEW SHARE CAPITAL REGISTERED	GL
30/06	HOFSETH BIOCARE ASA: ANNUAL GENERAL MEETING COMPLETED	GL
30/06	HOFSETH BIOCARE ASA: FIRST QUARTER 2026 FINANCIAL REPORT AND NEW COMMERCIAL UPDATE FOR CURRENT TRADING	GL
29/06	HOFSETH BIOCARE ASA: MANDATORY NOTIFICATION OF TRADE	GL
29/06	HOFSETH BIOCARE ASA: DISCLOSURES OF LARGE SHAREHOLDINGS	GL
29/06	HOFSETH BIOCARE ASA – VOTING UNDERTAKINGS SECURED IN RELATION TO PRIVATE PLACEMENT AND B-SHARE AMENDMENTS	GL
28/06	HOFSETH BIOCARE ASA: PRIVATE PLACEMENT SUCCESSFULLY PLACED	GL
26/06	HOFSETH BIOCARE ASA: CONTEMPLATED PRIVATE PLACEMENT	GL
09/06	Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2026	GL
22/05	Hofseth BioCare ASA: EXCLUSIVE LICENSE AND SUPPLY AGREEMENT SIGNED FOR PROGO FOR OVER $5M	GL
14/04	Hofseth BioCare ASA: HBC publishes paradigm-changing clinical trial results of OmeGo full spectrum omegas	GL
27/03	Hofseth BioCare ASA: HBC ANNUAL REPORT 2025	GL